ALNY
Alnylam Pharmaceuticals Inc
Price:  
245.26 
USD
Volume:  
673,293.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alnylam Probability of Bankruptcy

The Probability of Bankruptcy of Alnylam Pharmaceuticals Inc (ALNY) is 10.24% . This number represents the probability that Alnylam will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating Alnylam's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

Alnylam - ESG ratings

ESG ratings are directly linked to the cost of capital and Alnylam's ability to raise funding, both of which can significantly affect the probability of Alnylam Pharmaceuticals Inc going bankrupt.

ESG Score 69.55
Environment Score 55.20
Social Score 99.00
Governance Score 54.45
Returns
Historical Returns (5 day) -4.29%
Historical Returns (MTD) -3.09%
Historical Returns (YTD) 28.13%
Historical Returns (13 week) -6.29%
Historical Returns (26 week) 59.81%
Historical Returns (52 week) 35.86%
Efficiency
Asset Turnover 0.53
Receiveable Turnover 8.41
Gross Margin 85.37%
Operating Margin -8.98%
Pretax Margin -15.33%
Net Margin -15.86%
Return on Asset (ROA) -8.38
Return on Equity (ROE) -344.84
Return on Investments (ROI) -10.57
Price Metrics
Market Cap (M) 31,633.63
Enterprise Value (M)
52 Week High 304.39
52 Week Low 141.97
Beta 0.94
Average Volume (10 day) 0.50
Average Volume (3 month) 0.80
Price / Earnings (P/E)
Price / Sales (P/S) 15.65
Earnings
EPS -2.62
Revenue CAGR (5 year) 89.46%
Risk
Current Ratio 2.75
Quick Ratio 2.57